Extension of Time to File SOU

ALEVEX

Bayer HealthCare LLC

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88656051
LAW OFFICE ASSIGNED LAW OFFICE 125
MARK SECTION
MARK ALEVEX (see, http://uspto.report/TM/88656051/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT ALEVEX
OWNER SECTION (current)
NAME Bayer HealthCare LLC
MAILING ADDRESS 100 Bayer Boulevard
CITY Whippany
STATE New Jersey
ZIP/POSTAL CODE 07981
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
OWNER SECTION (proposed)
NAME Bayer HealthCare LLC
MAILING ADDRESS 100 Bayer Boulevard
CITY Whippany
STATE New Jersey
ZIP/POSTAL CODE 07981
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 314-694-6526
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Sondra Schol
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE bayertrademarkus@bayer.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
CORRESPONDENCE INFORMATION (proposed)
NAME Sondra Schol
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE bayertrademarkus@bayer.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) nicole.arendall@bayer.com
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 003
CURRENT IDENTIFICATION Non-medicated skin care preparations
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Preparation for the relief of pain; Topical analgesics; Transdermal patches featuring a nonsteroidal anti-inflammatory for use in treating pain, headaches, fever, inflammation, common cold symptoms, and joint stiffness; Transdermal patches for use in the treatment of pain, headaches, fever, inflammation, common cold symptoms, and joint stiffness
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 04/28/2020
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 2
SUBTOTAL AMOUNT [EXTENSION FEE] 250
TOTAL AMOUNT 250
SIGNATURE SECTION
SIGNATURE /Sondra Schol/
SIGNATORY'S NAME Sondra Schol
SIGNATORY'S POSITION Senior Assistant General Counsel, Trademarks
DATE SIGNED 10/20/2020
SIGNATORY'S PHONE NUMBER 314-694-6526
FILING INFORMATION
SUBMIT DATE Wed Oct 21 12:44:52 ET 2020
TEAS STAMP USPTO/ESU-XXX.XXX.XXX.XXX
-20201021124452451692-886
56051-7502db9fb7e50f37c3d
e9ce12c67b638115d4e3c2db2
e593f6bd8ed3a169c7804d-CC
-44511327-202010201517553
21074



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: ALEVEX (see, http://uspto.report/TM/88656051/mark.png)
SERIAL NUMBER: 88656051

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Bayer HealthCare LLC, having an address of
      100 Bayer Boulevard
      Whippany, New Jersey 07981
      United States
Proposed: Bayer HealthCare LLC, having an address of
      100 Bayer Boulevard
      Whippany, New Jersey 07981
      United States
      Phone: 314-694-6526
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 04/28/2020.

For International Class 003:
Current identification: Non-medicated skin care preparations

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 005:
Current identification: Preparation for the relief of pain; Topical analgesics; Transdermal patches featuring a nonsteroidal anti-inflammatory for use in treating pain, headaches, fever, inflammation, common cold symptoms, and joint stiffness; Transdermal patches for use in the treatment of pain, headaches, fever, inflammation, common cold symptoms, and joint stiffness

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

Correspondence Information (current):
      Sondra Schol
      PRIMARY EMAIL FOR CORRESPONDENCE: bayertrademarkus@bayer.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED

Correspondence Information (proposed):
      Sondra Schol
      PRIMARY EMAIL FOR CORRESPONDENCE: bayertrademarkus@bayer.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): nicole.arendall@bayer.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Sondra Schol/      Date Signed: 10/20/2020
Signatory's Name: Sondra Schol
Signatory's Position: Senior Assistant General Counsel, Trademarks
Signatory's Phone: 314-694-6526

RAM Sale Number: 88656051
RAM Accounting Date: 10/21/2020

Serial Number: 88656051
Internet Transmission Date: Wed Oct 21 12:44:52 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XXX.XXX.XXX-20201021124452
451692-88656051-7502db9fb7e50f37c3de9ce1
2c67b638115d4e3c2db2e593f6bd8ed3a169c780
4d-CC-44511327-20201020151755321074




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed